First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
The new ECO grade is made using renewable feedstock
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
Total transaction value of the divestment is Rs. 3,660 million
The companies plan to start a pivotal Phase 3 trial in the coming months
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Subscribe To Our Newsletter & Stay Updated
